Pseudo-Wellens' Syndrome Temporally Associated With Immune Check Point Inhibitors Use. - 2020


English

0002-9629

10.1016/j.amjms.2019.07.006 [doi] S0002-9629(19)30283-6 [pii]


*Arrhythmias, Cardiac/et [Etiology]
*Ipilimumab/ae [Adverse Effects]
*Ipilimumab/tu [Therapeutic Use]
*Nivolumab/ae [Adverse Effects]
*Nivolumab/tu [Therapeutic Use]
Adrenergic alpha-1 Receptor Antagonists/tu [Therapeutic Use]
Aged
Angiotensin II Type 1 Receptor Blockers/tu [Therapeutic Use]
Antineoplastic Agents, Immunological/ad [Administration & Dosage]
Antineoplastic Agents, Immunological/ae [Adverse Effects]
Antineoplastic Agents, Immunological/tu [Therapeutic Use]
Anus Neoplasms/dt [Drug Therapy]
Arrhythmias, Cardiac/di [Diagnosis]
Arrhythmias, Cardiac/dt [Drug Therapy]
Benzimidazoles/tu [Therapeutic Use]
Carvedilol/tu [Therapeutic Use]
Drug Therapy, Combination/ae [Adverse Effects]
Humans
Ipilimumab/ad [Administration & Dosage]
Male
Melanoma/dt [Drug Therapy]
Nivolumab/ad [Administration & Dosage]
Rectal Diseases
Rectal Neoplasms/dt [Drug Therapy]
Tetrazoles/tu [Therapeutic Use]


MedStar Washington Hospital Center


Medicine/Internal Medicine


Letter